In the two weeks since Hurricane Maria devastated the island of Puerto Rico, federal officials and medical supply companies have been working hard to prevent shortages of lifesaving and life-extending products manufactured on the island.
But that's tough to do without a functioning power grid.
About 23 medical device companies including Medtronic PLC and Boston Scientific Corp. have facilities on the island, including manufacturing sites that churn out everything from pacemakers to trauma-surgery products. As of Friday, some of the factories are up and running again on generator power, but none is working at full capacity, according to an assessment from Washington-based industry trade group AdvaMed.
AdvaMed said in an Oct. 4 letter to federal officials that once the island's immediate humanitarian needs are met, federal officials should consider prioritizing the re-establishment of power and phone service to med-tech companies on the island, given their importance to the island's economy and to patients in the region and around the world who need the health products produced there.
"This storm has been so destructive across the entire island and the work that our companies do so directly impacts the health care system and the patients who need access to these products," AdvaMed CEO Scott Whitaker said Friday. "If we're not prioritized, we're concerned that patients won't get the products they need and the supply chain will be negatively impacted by that."
It wasn't clear specifically which medical devices made on the island would be vulnerable to shortages.
Dr. Scott Gottlieb, commissioner of the Food and Drug Administration, said in a statement Friday that the drugs, biologics and medical devices manufactured on the island account for about 30 percent of Puerto Rico's entire gross domestic product. And more than three-quarters of the pharmaceuticals made on the island are consumed by U.S. citizens in Puerto Rico and in the 50 states.
"Securing this manufacturing base is vital to maintaining access to many important medical products," Gottlieb's statement said. "We're keeping a close watch on the most critical medical products."